Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 9:12 AM ISTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
New AstraZeneca, Amgen drug looks strong rival in severe asthma Ruby Khatun Khatun11 Sept 2017 10:27 AM ISTLONDON: A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than...
Amgen and Humana partner for improved health outcomes and efficiency Ruby Khatun Khatun21 Aug 2017 10:00 AM ISTTHOUSAND OAKS, Calif. and LOUISVILLE: Two of the nation's leading health organizations, health and well-being company Humana Inc. and biotechnology...
FDA rejects Coherus' biosimilar for Amgen's Neulasta Ruby Khatun Khatun13 Jun 2017 9:12 AM ISTn" style="transform: translate3d(0px, 0px, 0px);"Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the...
Dr Reddy Labs inks pact with Amgen to market three drugs in India savita thakur thakur18 Sept 2016 9:34 AM ISTHyderabad : Dr Reddy's Laboratories (DRL) has expanded its strategic collaboration with US based independent biotechnology firm Amgen to market and...